poisar

Stocks · News reference

Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $100

BenzingaJul 21, 2026, 11:29 AMBenzinga Newsdesk

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $76 to $100.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 21, 2026, 11:29 AM
Checked
Jul 21, 2026, 11:29 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARAug 21, 2026, 8:26 PMSEC EDGAR

    8-K filing — Hinge Health, Inc. (HNGE)

    Filed: 2026-08-21 AccNo: 0001628280-26-058439 Size: 149 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

    Read original at edgar